NLS
June 24, 2017
Published: June 24, 2017
Top stories
MedTech Business – June 9, 2026
The company has secured two major hospital contracts in Sweden and France, with a combined value of approximately SEK 16 million.
In a new job – June 9, 2026
The company is strengthening its focus on new partnerships through the appointment of Raheleh Nassaji as Senior Vice President Business Development.
Global report – June 9, 2026
SOPHiA Genetics has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two institutions.
Agreement – June 9, 2026
AlzeCure Pharma has entered into a collaboration and out-licensing agreement with the pharmaceutical company Eli Lilly and Company regarding the global rights to the Alzheimer’s project Alzstatin ACD680.
Related posts
contentsubscribe - June 25, 2017
contentsubscribe - June 23, 2017
contentsubscribe - June 22, 2017
contentsubscribe - June 21, 2017
Bio-Europe Spring 2017 ChinaBio Partnering Forum 2017 BioPharm America 2017 Bio-Europe 2017 Biolatam 2017
This site uses cookies
Read more about our privacy policy
The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.
The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.
The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.